European Healthtech startup funding raised during Q4 2024.
In Q4 2024, 104 European Healthtech companies raised a combined €1.8B across 105 funding rounds, up 104.5% versus Q4 2023. Switzerland led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Cimeio Therapeutics | Other | Dec 2024 | €282M |
| ŌURA | Series D+ | Dec 2024 | €192M |
| Citryll | Series B | Dec 2024 | €85M |
| Agomab Therapeutics | Series D+ |
3 exits · €50M disclosed.
| Lamidey Noury Medical | Acquisition | Nov 2024 | €50M |
| Oct 2024 |
| €83M |
| Antag Therapeutics | Series A | Dec 2024 | €80M |
| ŌURA | Series D+ | Nov 2024 | €71M |
| Cradle | Series B | Nov 2024 | €69M |
| Nuclera | Series A | Oct 2024 | €69M |
| Quanta Dialysis Technologies | Series D+ | Nov 2024 | €57M |
| Basecamp Research | Series B | Oct 2024 | €55M |
| Inbrain Neuroelectronics | Series B | Oct 2024 | €46M |
| Aqemia | Other | Dec 2024 | €36M |
| Aignostics | Series B | Oct 2024 | €32M |
| Inotec Amd | Series C | Dec 2024 | €31M |
| Midiagnostics | Series D+ | Dec 2024 | €30M |
